Okay. Good day. Ladies and gentlemen, welcome to the Annual General Meeting of shareholders of Haoxi Health Technology. I'm Zhen Fan, the CEO and the Chairman of the Board of Directors of the company. We are chairing the meeting in accordance with the Articles of Association of the company. It is a pleasure to welcome you to the Annual General Meeting of shareholders. Our outside legal counsel, Ms. Goh Lu, the service advisor, secretary of the meeting. Now, I would like to turn the meeting over to Jack Shi, our Director of Investor Relations, who will host the rest of today's meeting. Thank you.
Thank you, Mr. Fan. So let me begin by calling our Annual General Meeting of shareholders to order. The purpose of this meeting is to consider, and if thought fit, approve. One, as an ordinary resolution to approve the authorization of the company's Board of Directors to effect the share consolidation of the company's authorized and issued share capital at a ratio of 1 for 25. Two, subject to the approval of the share consolidation as an ordinary resolution to approve the increase immediately after the share consolidation of the authorized share capital of the company to $1 million divided into 300 million Class A ordinary shares, par value $0.0025, and 100 million Class B ordinary shares, par value $0.0025.
Three, subject to the approval of the share consolidation and the increase of authorized shares as a special resolution to approve and adopt the amendment to the fourth amended and restated Memorandum and Articles of Association of the company currently in effect, the fourth amended M&A, to effect the share consolidation and/or the increase of the authorized shares and to the extent each is effected. Four, as an ordinary resolution to re-elect each of the five directors named in the proxy statement as a director of the company to hold office until the next Annual General Meeting or until the respective successor is elected and duly qualified. Five, as an ordinary resolution to ratify and confirm the appointment of Wei, Wei & Co., LLP as the company's independent auditors for the year ending June 30, 2024.
Six, as an ordinary resolution to approve the appointment of Wei, Wei & Co., LLP as the company's independent auditors for the year ending June 30, 2025. Seven, as an ordinary resolution to authorize the adjournment of the 2025 Annual General Meeting , if necessary, to solicit additional proxies if there are not sufficient votes at the time of the 2025 Annual General Meeting , or adjournment or postponement thereof to foregoing proposals. The full text of the resolutions is as set out in a notice of this meeting and your ballot paper. Notice of this meeting was contained in a notice to shareholders issued by the company and was dispatched to the shareholders on or around December 19, 2024. A copy of the notice of the meeting is available for inspection at this meeting and will be filed with the minutes of this meeting.
With your permission, I propose to take the notice as read. Louis Larson serves as our inspector of elections for this meeting and has signed the oath of office. The oath of the inspector will also be filed with the minutes of the meeting. I have in my possession a list of the company's shareholders of record as of the record date December 18, 2024. As of the record date, 53,289,874 shares of our Class A ordinary shares representing 53,289,874 votes and 17,270,000 shares of our Class B ordinary shares representing 172,700,000 votes were outstanding and are entitled to vote at the 2025 annual meeting. Holders of Class A ordinary shares and Class B ordinary shares will be voting together as a single class on all proposals to be voted on at the 2025 annual meeting.
On a vote by way of poll, each company's Class A ordinary shares shall be entitled to vote one vote on all matters subject to vote at general meetings of the company. Each company's Class B ordinary shares shall be entitled to 10 votes on all matters subject to vote at general meetings of the company. At the commencement of this meeting, there are present in person or by proxy at the meeting shareholders shown by such list to be the holders of 13,471,026 out of a total of 53,289,874 Class A ordinary shares issued and outstanding and carrying the right to vote at the meeting, and the holders of 12,270,000 out of a total of 17, I'm sorry, 17,270,000 out of a total of 17,270,000 Class B ordinary shares.
More than one-third of the Class A ordinary shares and Class B ordinary shares voting together as a single class entitled to vote at the extraordinary meeting are represented in person or by proxy, and hence a quorum is present. Accordingly, this meeting is duly convened and quorate.
Thank you. All resolutions to be proposed at this meeting will be voted upon by way of poll such that each shareholder shall have one vote for each ordinary share. The polls are now opened and will be closed after the reading of the proposals. I hereby propose the following resolutions for the shareholders' consideration and if those fit, approval. Resolution One, Share Consolidation as an Ordinary Resolution to Approve, Confirm, Ratify the Share Consolidation Proposal. Resolution Two, Share Capital Reorganization Proposal. Resolution Three, Amended and Restated Memorandum and Articles of Association Proposal. Resolution Four, The Re-election of Directors Proposal. Resolution Five, Auditor Ratification Proposal. Resolution Six, Auditor Appointment Proposal. Resolution Seven, Authorization to Adjourn the Meeting Proposal. The polls are now closed for voting.
The votes submitted are as follows. For Resolution One, a total of 186,171,026 votes were cast. There were 185,427,942 representing 99.60% votes for and 725,731 votes representing 0.38% votes against the resolution, and 17,533 votes were abstained. For Resolution Two, a total of 186,171,026 votes were cast. There were 185,418,781 representing 99.59% votes for and 738,448 representing 0.39% votes against the resolution, and 13,797 votes were abstained. For Resolution Three, a total of 186,171,026 votes were cast. There were 185,505,862 representing 99.64% votes for and 593,073 votes representing 0.31% votes against the resolution, and 72,091 votes were abstained. For Resolution Four, a total of 186,171,026 votes were cast. There were 185,925,048 representing 99.86% votes for and 212,034 representing 0.11% votes against the resolution, and 33,944 votes were abstained. For Resolution Five, a total of 186,171,026 votes were cast.
There were 185,969,084 representing 99.89% votes for and 174,198 representing 0.09% votes against the resolution, and 27,744 votes were abstained. For Resolution Six, a total of 186,171,026 votes were cast. There were 185,977,943 representing 99.89% votes for and 178,539 representing 0.09% votes against the resolution, and 14,544 votes were abstained. For Resolution Six, a total of 186,171,026 votes were cast. There were 185,946,029 representing 99.87% votes for and 196,602 representing 0.10% votes against the resolution, and 28,395,000 votes were abstained.
With the results of these votes, I declare that all resolutions have been duly passed by the company. Thank you, everyone, again for attending Haoxi Health Technology Limited's 2025 Annual General Meeting of Shareholders. This concludes our meeting today, and we thank you all for attending in. Goodbye.